Molly Ware is a Cardiology physician affiliated with Boulder Community Hospital. OpenAlex indexes 6 publications with 221 citations (h-index 2).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20259 payments
- HEARTFLOW, INC.Program year20251 payment
- Boston Scientific CorporationProgram year202419 payments$10,102openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.1%Statin25.3%Atorvastatin Calcium54%Rosuvastatin Calcium45%Pravastatin Sodium2%Part D<11 patientsBeta blocker19.8%Metoprolol Succinate58%Carvedilol19%Metoprolol Tartrate15%Nebivolol Hcl8%Part D≥106 patients+ 10 more classes in this area
Blood & clotting
13%Factor Xa inhibitor9.5%Eliquis94%Xarelto6%Part D<11 patientsP2Y12 inhibitor2.5%Clopidogrel100%Part D≥20 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.4%SGLT2 inhibitor1.4%Jardiance69%Invokana31%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 700.32 Two Year Results of the Surgically Implanted Self-Expanding Supra-Annular Bioprosthesis Evolut
JACC: Cardiovascular Interventions
2025 - Surgical Aortic Valve Replacement Using a Supra-Annular Self-Expanding Bioprosthesis
JACC Case Reports
2024 - Heart Failure and Diabetes: Collateral Benefit of Chronic Disease Management
Congestive Heart Failure
2006 - Heart failure and diabetes: collateral benefit of chronic disease management?
Journal of Cardiac Failure
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”